Genprex, Inc. (GNPX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Genprex, Inc. (GNPX) is down 58.0% since the beginning of the year. At $1 per share, GNPX is trading 98.7% below its 52-week high of $55. Investors who bought $1,000 worth of GNPX shares 5 years ago would now be looking at an investment worth $0.

Genprex, Inc. (GNPX) has returned -57.99% so far this year and -94.87% over the past 12 months.

Based on dividend-adjusted daily data since Mar 29, 2018, GNPX's average daily return is +0.09%, while the average monthly return is +2.52%. At this rate, an investment would double in approximately 2.3 years.

Historically, 30% of months were positive and 70% were negative. The best month was Oct 2024 with a return of +522.1%, while the worst month was Jul 2018 at -60.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.

On a daily basis, GNPX closed higher 41% of trading days. The best single day was Oct 21, 2024 with a return of +265.6%, while the worst single day was Jul 27, 2018 at -54.6%.

Genprex, Inc. has an annualized alpha of 2.91%, beta of 1.35, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since April 02, 2018.

• This stock participated in 81.58% of S&P 500 Index downside but only -139.02% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

GNPX ranks 13 for risk / return — in the bottom 13% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Genprex, Inc. (GNPX) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Genprex, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Genprex, Inc. was 100.00%, occurring on Jun 2, 2026. The portfolio has not yet recovered.

The current Genprex, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Genprex, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Genprex, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.